Janux Therapeutics, Inc. - COMMON STOCK (JANX)
CUSIP: 47103J105
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 60,097,976
- Total 13F shares
- 27,496,946
- Share change
- +984,309
- Total reported value
- $541,627,745
- Price per share
- $19.73
- Number of holders
- 46
- Value change
- +$19,103,067
- Number of buys
- 23
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 47103J105?
CUSIP 47103J105 identifies JANX - Janux Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 47103J105:
Top shareholders of JANX - Janux Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
14%
|
8,670,644
|
$187,546,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
6%
|
3,615,431
|
$78,202,000 | — | 30 Sep 2021 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director |
5.8%
|
3,466,386
|
$74,978,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4%
|
2,416,404
|
$51,375,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.1%
|
1,859,246
|
$39,642,000 | — | 30 Sep 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.3%
|
1,411,975
|
$30,541,000 | — | 30 Sep 2021 | |
| Bregua Corp |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,749,250
|
$22,008,098 | — | 15 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
1.7%
|
1,017,314
|
$22,005,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
801,778
|
$17,341,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.88%
|
530,242
|
$11,470,000 | — | 30 Sep 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.74%
|
446,266
|
$9,653,000 | — | 30 Sep 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.69%
|
411,871
|
$8,909,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.67%
|
400,000
|
$8,652,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.5%
|
300,031
|
$6,490,000 | — | 30 Sep 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.41%
|
247,122
|
$4,811,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
211,880
|
$4,582,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.29%
|
174,644
|
$3,778,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
116,961
|
$2,530,000 | — | 30 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.11%
|
65,414
|
$1,415,000 | — | 30 Sep 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.1%
|
59,366
|
$1,284,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
46,156
|
$998,000 | — | 30 Sep 2021 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.07%
|
40,860
|
$884,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
32,576
|
$705,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
31,473
|
$681,000 | — | 30 Sep 2021 | |
| Parkwood LLC |
13F
|
Company |
0.03%
|
20,777
|
$449,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
19,457
|
$421,000 | — | 30 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
11,110
|
$240,000 | — | 30 Sep 2021 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.02%
|
9,458
|
$235,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
8,185
|
$178,000 | — | 30 Sep 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
7,242
|
$157,000 | — | 30 Sep 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
7,149
|
$155,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,694
|
$145,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
6,474
|
$140,000 | — | 30 Sep 2021 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
5,302
|
$114,682 | — | 30 Sep 2021 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0.01%
|
4,011
|
$86,758 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,500
|
$76,000 | — | 30 Sep 2021 | |
| STRS OHIO |
13F
|
Company |
0%
|
3,000
|
$64,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,918
|
$63,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,837
|
$61,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
2,300
|
$50,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,755
|
$38,000 | — | 30 Sep 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,239
|
$27,000 | — | 30 Sep 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,014
|
$22,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
502
|
$11,000 | — | 30 Sep 2021 | |
| Evolution Wealth Advisors, LLC |
13F
|
Company |
0%
|
124
|
$3,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
74
|
$2,000 | — | 30 Sep 2021 |
Institutional Holders of Janux Therapeutics, Inc. - COMMON STOCK (JANX) as of Q4 2021
As of 31 Dec 2021,
Janux Therapeutics, Inc. - COMMON STOCK (JANX) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,496,946 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, EcoR1 Capital, LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, and 5AM Venture Management, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
44
Q4 2021 holders
46
Holder diff
2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.